Ozempic, manufactured by Novo Nordisk, is an injectable medication used to treat type 2 diabetes
Experiencing both vomiting and diarrhea can be distressing, leaving you feeling weak and anxious about continuing the medication
Approval (2017) Once-Weekly Semaglutide in Adults With Overweight or Obesity (March 2021) Efficacy of Semaglutide in a Subcutaneous and an Oral Formulation (June 25, 2021) Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (November 11, 2023) Ozempic Side Effects Two-Year Effects Of Semaglutide In Adults With Overweight Or Obesity: The STEP 5 Trial (October 10, 2022) The Pathophysiology Of Chronic Constipation (October 2011) Dietary Guidelines for Americans, 2020-2025
Clinical trials supporting semaglutide for weight loss enrolled patients who took their injection on the same day every week, so treatment outcomes reflect that adherence pattern
18 In the context of IIH pathophysiology, the use of GLP-1 RAs extends beyond the weight-modifying effects (figure)